RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice is a research paper published in Journal of Bone and Mineral Research (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Cancer Society
Grant: 132013-RSG-18-010-01-CCG
National Cancer Institute
Grant: R01CA122596
National Cancer Institute
Grant: R01CA194593
National Institute of Aging
Grant: PO1AG039355
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01AR079379
Veterans Administration
Grant: 1I01-BX004177-01
American Cancer Society
Grant: 132013‐RSG‐18‐010‐01‐CCG
NIA NIH HHS
Grant: P01 AG039355
NIAMS NIH HHS
Grant: T32 AR065971
NCI NIH HHS
Grant: P30 CA082709
BLRD VA
Grant: I01 BX004177
National Institutes of Health
Grant: 3P30CA082709-16S3
Indiana University Melvin and Bren Simon Cancer Center Support Grant
National Institutes of Health
Grant: 7R01AR079379-03
Targeting RANKL for the treatment of muscle and bone defects in cachexia
National Institutes of Health
Grant: 1R01CA122596-01A2
Manipulation of STAT3 Signaling for Muscle Preservation in Cancer Cachexia
National Institutes of Health
Grant: 5R01CA194593-03
PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer Cachexia
Lustgarten Foundation
Ralph W. and Grace M. Showalter Research Trust Fund
FWCI
1.92
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals